Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 27, 2018
Boston Scientific will participate in Citi’s healthcare investor conference in December 2018. A live webcast and replay will be available.
-
Nov 25, 2018
In helping care for people living with complex, debilitating and often life-threatening conditions, patient safety is Boston Scientific’s highest priority.
-
Nov 21, 2018
Boston Scientific will participate the healthcare investor conference in November 2018. A live webcast and replay will be available.
-
Nov 20, 2018Transaction would expand peripheral interventions portfolio with minimally-invasive treatments for cancers and vascular conditions
Transaction would expand Boston Scientific peripheral interventions portfolio with minimally invasive treatments for cancers and vascular conditions
-
Nov 7, 2018
Boston Scientific will participate in a medtech conference in November 2018. A live webcast and replay will be available.
-
Nov 6, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 in New York City. Dan Brennan, executive vice president and chief...
-
Nov 6, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the 27th Annual Credit Suisse Healthcare Conference on Wednesday, November 14, 2018 in Scottsdale, Arizona. Joe Fitzgerald, executive...
-
Oct 24, 2018
"Through internal research and tuck-in acquisitions, we continue to bring meaningful innovations to market,” said CEO Mike Mahoney.
-
Oct 23, 2018Court Rules Edwards Lifesciences' Next-Generation Valve Infringes Boston Scientific Patent and Grants Right to Enjoin Sales in Germany
Court rules Edwards Lifesciences’ next-generation valve infringes Boston Scientific patent and grants right to enjoin sales in Germany.
-
Oct 16, 2018
The acquisition brings SpaceOAR, which decreases exposure to rectal radiation during prostate cancer radiotherapy, into the Boston Scientific portfolio.